Single Lab Test

Gynecologic Pap Test, Liquid-based Preparation and Chlamydia/Gonococcus/Trichomonas, NAA

Back to Search
Categories
Turnaround Time
3 - 6 days
CPT Code
87,591,876,618,814,200,000
Test Type

Cervical cells

Overview

Diagnose primary or metastatic neoplasm; detect Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.

Failure to obtain adequate ectocervical, endocervical, or vaginal cell population is suboptimal for evaluation. Excessive use of lubricating jelly on the vaginal speculum will interfere with cytologic examination and may lead to unsatisfactory Pap results.

Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis requires special procedures to be used in the processing of the cytology specimens; therefore, testing for these organisms cannot be added on after the specimen has been submitted. The liquid-based cytology specimen must be processed for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing.

Any time a transport device used for molecular testing is processed, the chance of cross specimen contamination increases. Aptima® transports can be placed directly on the analyzer, limiting the possibility of cross specimen contamination.

Centers for Disease Control and Prevention. Screening Test to Detect Chlamydia trachomatis and Neisseria gonorrhoeae-2002. MMWR. 2002; 51(RR15). PubMed 12418541

Hutchinson ML, Cassin CM, Harrison GB. The efficacy of an automated preparation device for cervical cytology. Am J Clin Pathol. 1991; 96(3):300-305. PubMed 1877527

Hutchinson ML, Isenstein LM, Goodman A, et al. Homogeneous sampling accounts for the increased diagnostic accuracy uising the ThinPrep® Processor. Am J Clin Pathol. 1994; 101(2):215-219. PubMed 8116578

Joseph MG, Cragg F, Wright VC, et al. Cytohistological correlates in a colposcopic clinic: A 1-year prospective study. Diagn Cytopathol. 1991; 7(5):477-481. PubMed 1954825

van Der Schee C, van Belkum A, Zwijgers L, et al. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimen compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol. 1999; 37(12):4127-4130. PubMed 10565943

Wilbur DC, Cibas ES, Merritt S, et al. ThinPrep® Processor: Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens. Am J Clin Pathol. 1994; 101(2):209-214. PubMed 8116577

Collection Details

Patient Preparation:

Patient should avoid douches 48 to 72 hours prior to examination. Specimen should not be collected during or shortly after menstrual period.

Collection Instructions:

Discover the Evexia advantage

Start Ordering Today

Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.